Cimzia 2X200 MG/ML syringe kits
Ended Awarded Last action
- Contract number
- SPE2DR26FG3MA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,223
Award facts
- Contract value 100% obligated
- $10,222.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,222.84 delivery order to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 16, 2026, for the supply of CIMZIA 2X200 MG/ML syringe kits. The contract carries a firm fixed-price structure with an ultimate completion date of January 20, 2026, and represents a non-set-aside, competitively awarded procurement. The awardee, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerSourceBergen's parent company, Cencora, Inc. (doing business as AmerSourceBergen), which maintains a substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031.
This delivery order fulfills critical pharmaceutical supply needs for military healthcare systems through the broader DLA medical supply chain. CIMZIA is a biologic medication used for treating inflammatory conditions and is essential for maintaining adequate pharmaceutical inventory across Defense Health Agency treatment facilities and military medical installations. The award demonstrates AmerSourceBergen's continued capability to efficiently execute small-value, time-sensitive medical procurement requirements through its existing IDC vehicle, which enables rapid fulfillment of essential pharmaceutical commodities to support military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FG3MA?
SPE2DR26FG3MA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26FG3MA worth?
The government has obligated $10,223 on SPE2DR26FG3MA.
Is contract SPE2DR26FG3MA an order under another contract?
Yes. SPE2DR26FG3MA is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG3MA competed?
The extent of competition for SPE2DR26FG3MA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award